Bliss GVS Pharma P/E Ratio

BLISSGVS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
21.67
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 21.67
Current Price ₹237.04
EPS (TTM) ₹8.02
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 15.6
Historical Range 8.59 - 21.47
Percentile 100.0%

Sector Context

Sector Average 47.68
Sector Median 25.75
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹10.33
Sept 2025 ₹2.58
Mar 2025 ₹1.47

Key P/E Ratio Insights for Bliss GVS Pharma

  • Current PE is 38.9% above historical average
  • Trading at discount to sector average PE of 47.68

P/E Ratio Historical Trend for Bliss GVS Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 17.18 10.33 ₹177.48 NSE Moderate
2023 8.59 8.45 ₹72.60 NSE Low
2022 12.36 8.39 ₹103.70 NSE Low
2020 21.47 6.89 ₹147.90 NSE Moderate
2019 15.76 10.34 ₹163.00 NSE Moderate
2017 13.28 11.93 ₹158.40 NSE Low
2016 20.53 8.86 ₹181.90 NSE Moderate

Sector P/E Ratio Comparison

Comparing Bliss GVS Pharma with other companies in Healthcare sector
Sector Average
47.68
Sector Median
25.75
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low